Journal
PHARMACOGENETICS AND GENOMICS
Volume 22, Issue 6, Pages 466-470Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FPC.0b013e32834aeedb
Keywords
CYP2C19; CYP2C9; HLA-B; pathway; pharmacogenomic; pharmacokinetics; phenytoin; SCN1A
Funding
- NIH/NIGMS [U01GM61374]